VREX

Varex Imaging Corporation

Price

$18.46

return (12m)

63.80%

p/e

35.13

p/bv

1.52

DIVIDEND YIELD

0.00%

VREX price

Varex Imaging

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment VREX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

72.20%

3 months

82.23%

1 year

63.80%

2 years

46.16%

5 years

-33.04%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals VREX

Valuation

P/E

35.13

Sector -2.19

Industry 1.21

P/BV

1.52

Sector 2.22

Industry 2.11

P/Revenue (PSR)

0.90

Sector 2.01

Industry 0.78

EV/EBITDA

35.05

Sector -17.81

Industry -25.30

EV/EBIT

46.36

Sector -26.72

Industry -18.04

P/EBITDA

9.35

Sector 0.36

Industry 0.18

P/EBIT

13.94

Sector -3.34

Industry 1.26

P/Total Assets

0.71

Sector 1.23

Industry 0.86

P/Net Current Assets

17.81

Sector -27.35

Industry -12.37

P/Working Capital

1.74

Sector -4.54

Industry -49.48

EPS

0.53

Sector -0.87

Industry -0.55

BVPS

12.15

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

34.32%

Sector 43.36%

Industry 31.53%

EBITDA Margin

13.63%

Sector -323.65%

Industry -73.39%

EBIT Margin

10.31%

Sector -194.57%

Industry -11.94%

Operating Margin

8.35%

Sector -24.37%

Industry -9.87%

Net Profit Margins

2.55%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.19

Sector 0.12

Industry 0.22

Profitability

ROE

4.33%

Sector -33.82%

Industry -37.56%

ROA

2.01%

Sector -29.63%

Industry -17.56%

ROIC

10.03%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

3.38

Sector 1.84

Industry 1.14

Net Debt / EBITDA

8.00

Sector -1.47

Industry -31.86

Net Debt / EBIT

10.59

Sector -1.32

Industry 2.06

Net Debt / Equity

0.45

Sector -0.35

Industry 0.14

Gross Debt / Equity

0.64

Sector 0.14

Industry 0.51

Equity/Assets

0.46

Sector 0.42

Industry 0.25

Liabilities/Assets

0.54

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

0.59%

Sector -

Industry -

5Y Earnings CAGR

-2.59%

Sector -

Industry -

FAIR VALUE OF Varex Imaging ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$18.46

Fair Value

$12.04

Upside Return potential.

-34.79%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals VREX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
VREX Varex Imaging Corporation	$18.46	67.36%	0.00%	35.13	1.52	4.33%	2.55%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%
DXCM DexCom Inc.	$89.88	11.21%	0.00%	34.58	13.19	38.14%	20.12%
EW Edwards Lifesciences Corp.	$92.28	17.85%	0.00%	52.70	4.94	9.37%	15.43%
BDX Becton Dickinson and Company	$187.60	-0.85%	2.30%	53.25	2.05	3.85%	4.05%
IMRA Imara Inc.	$0.00	-100.00%	92.02%	65.05	1.13	1.74%	0.00%
BDXB Becton Dickinson and Company	$0.00	-100.00%	0.00%	8.75	0.54	6.12%	8.36%
ALGN Align Technology Inc.	$163.04	13.40%	0.00%	28.99	2.83	9.77%	9.99%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
IRMD iRadimed Corporation	$87.40	26.40%	1.45%	48.10	10.90	22.66%	26.71%
SNN Smith & Nephew PLC	$29.30	-16.53%	2.61%	11.16	2.43	21.74%	9.20%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

VREX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Varex Imaging

Varex Imaging Corporation

Average Investor10 user rating

4.0 (1 people)

United States

10 years

Founded: 2016

2017

Time since IPO - 9 years

2.100

Employees

Varex Imaging Corporation (United States) is listed on the Nasdaq and has a market capitalization of $776.37 million, with shareholders equity totaling $510.50 million.

The company employs approximately 2.100 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Varex Imaging Corporation reported $865.00 million in revenue, generating net income of $22.10 million.

Key financial metrics include a P/E ratio of 35.13, a price-to-book (P/B) ratio of 1.52, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker VREX.

Market cap

$776.37 million

Net worth

$510.50 million

$510,500,000.00

Assets

$1.10 billion

$1,100,000,000.00

Total Shares Outstanding

42.00 million

42,000,000

Average Daily Trading Volume

$776.04 Thousand

$776,036.00

Sector

Health

Industry

Medical Supplies and Equipment

VREX

VREX revenue and profits

Financial Results VREX

DRAG THE FRAME TO SEE MORE DATA

VREX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87